{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T19:03:40Z","timestamp":1773342220076,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00228-025-03938-z","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T07:00:49Z","timestamp":1770361249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of eGFR estimation methods on drug dosing in pediatric ICU: a study of serum creatinine vs. cystatin C"],"prefix":"10.1007","volume":"82","author":[{"given":"Abrar","family":"Samman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneera","family":"Al-Jelaify","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afnan","family":"Alsunaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad-Hani","family":"Temsah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid A.","family":"Alhasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Alsultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"3","key":"3938_CR1","first-page":"233","volume":"37","author":"M Zaffanello","year":"2007","unstructured":"Zaffanello M, Franchini M, Fanos V (2007) Is serum Cystatin-C a suitable marker of renal function in children? Ann Clin Lab Sci 37(3):233\u2013240","journal-title":"Ann Clin Lab Sci"},{"issue":"4","key":"3938_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1208\/s12248-011-9301-x","volume":"13","author":"TC Fuchs","year":"2011","unstructured":"Fuchs TC, Hewitt P (2011) Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology. AAPS J 13(4):615\u2013631","journal-title":"AAPS J"},{"key":"3938_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051336","author":"KJ Downes","year":"2023","unstructured":"Downes KJ, Zuppa AF, Sharova A, Neely MN (2023) Optimizing vancomycin therapy in critically ill children: a population pharmacokinetics study to inform vancomycin area under the curve estimation using novel biomarkers. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15051336","journal-title":"Pharmaceutics"},{"issue":"10","key":"3938_CR4","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00467-003-1271-5","volume":"18","author":"G Filler","year":"2003","unstructured":"Filler G, Lepage N (2003) Should the Schwartz formula for estimation of GFR be replaced by Cystatin C formula? Pediatr Nephrol 18(10):981\u2013985","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"3938_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00467-013-2586-5","volume":"29","author":"N Ataei","year":"2014","unstructured":"Ataei N, Bazargani B, Ameli S, Madani A, Javadilarijani F, Moghtaderi M et al (2014) Early detection of acute kidney injury by serum Cystatin C in critically ill children. Pediatr Nephrol 29(1):133\u2013138","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"3938_CR6","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","volume":"38","author":"RD Perrone","year":"1992","unstructured":"Perrone RD, Madias NE, Levey AS (1992) Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38(10):1933\u20131953","journal-title":"Clin Chem"},{"issue":"6","key":"3938_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ki.2009.544","volume":"77","author":"MD Breyer","year":"2010","unstructured":"Breyer MD, Qi Z (2010) Better nephrology for mice\u2013and man. Kidney Int 77(6):487\u2013489","journal-title":"Kidney Int"},{"key":"3938_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/bs.acc.2014.11.007","volume":"68","author":"A Onopiuk","year":"2015","unstructured":"Onopiuk A, Tokarzewicz A, Gorodkiewicz E (2015) Cystatin C: a kidney function biomarker. Adv Clin Chem 68:57\u201369","journal-title":"Adv Clin Chem"},{"key":"3938_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/biom13071075","author":"S Spencer","year":"2023","unstructured":"Spencer S, Desborough R, Bhandari S (2023) Should cystatin C eGFR become routine clinical practice? Biomolecules. https:\/\/doi.org\/10.3390\/biom13071075","journal-title":"Biomolecules"},{"issue":"3","key":"3938_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.mayocp.2018.08.002","volume":"94","author":"EF Barreto","year":"2019","unstructured":"Barreto EF, Rule AD, Murad MH, Kashani KB, Lieske JC, Erwin PJ et al (2019) Prediction of the renal elimination of drugs with cystatin C vs creatinine: a systematic review. Mayo Clin Proc 94(3):500\u201314","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"3938_CR11","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/FTD.0000000000000796","volume":"42","author":"KJ Downes","year":"2020","unstructured":"Downes KJ, Zane NR, Zuppa AF (2020) Effect of Cystatin C on Vancomycin clearance Estimation in critically ill children using a population Pharmacokinetic modeling approach. Ther Drug Monit 42(6):848\u2013855","journal-title":"Ther Drug Monit"},{"issue":"10","key":"3938_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/phar.2617","volume":"41","author":"DH Rhoney","year":"2021","unstructured":"Rhoney DH, Metzger SA, Nelson NR (2021) Scoping review of augmented renal clearance in critically ill pediatric patients. Pharmacotherapy 41(10):851\u2013863","journal-title":"Pharmacotherapy"},{"issue":"4","key":"3938_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40272-023-00572-z","volume":"25","author":"M Raina","year":"2023","unstructured":"Raina M, Ashraf A, Soundararajan A, Mandal AK, Sethi SK (2023) Pharmacokinetics in critically ill children with acute kidney injury. Paediatr Drugs 25(4):425\u2013442","journal-title":"Paediatr Drugs"},{"issue":"6","key":"3938_CR14","doi-asserted-by":"publisher","first-page":"e788","DOI":"10.1097\/PCC.0000000000003727","volume":"26","author":"L Xu","year":"2025","unstructured":"Xu L, Xu J, Mao H, Qian W, Ma Z, Zhang Y et al (2025) Prevalence and associated explanatory factors for augmented renal clearance in early sepsis: Single-Center, retrospective PICU cohort in China, 2022\u20132023. Pediatr Crit Care Med 26(6):e788\u2013e95","journal-title":"Pediatr Crit Care Med"},{"key":"3938_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2023.09.008","author":"A Alsultan","year":"2024","unstructured":"Alsultan A, Aldawsari MR, Alturaiq NK, Syed SA, Alsubai A, Kurdee Z et al (2024) Evaluation of pharmacokinetic pharmacodynamic target attainment of meropenem in pediatric patients. Pediatr Neonatol. https:\/\/doi.org\/10.1016\/j.pedneo.2023.09.008","journal-title":"Pediatr Neonatol"},{"issue":"2","key":"3938_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40262-019-00813-w","volume":"59","author":"SJF Hartman","year":"2020","unstructured":"Hartman SJF, Br\u00fcggemann RJ, Orri\u00ebns L, Dia N, Schreuder MF, de Wildt SN (2020) Pharmacokinetics and target attainment of antibiotics in critically ill children: A systematic review of current literature. Clin Pharmacokinet 59(2):173\u2013205","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"3938_CR17","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1111\/bcp.14084","volume":"85","author":"N Sosnin","year":"2019","unstructured":"Sosnin N, Curtis N, Cranswick N, Chiletti R, Gwee A (2019) Vancomycin is commonly under-dosed in critically ill children and neonates. Br J Clin Pharmacol 85(11):2591\u20132598","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"3938_CR18","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1111\/bcp.14733","volume":"87","author":"Y Oh","year":"2021","unstructured":"Oh Y, Park S, Park E, Lee J, Lee H, Kim J et al (2021) Correlation between Vancomycin clearance and Cystatin C-based glomerular filtration rate in paediatric patients. Br J Clin Pharmacol 87(8):3190\u20133196","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"3938_CR19","first-page":"614","volume":"30","author":"HR Hambrick","year":"2024","unstructured":"Hambrick HR, Fei L, Pavia K, Kaplan J, Mizuno T, Tang P et al (2024) Cystatin C outperforms creatinine in predicting cefepime clearance in pediatric stem cell transplant recipients. Transpl Cell Ther 30(6):614","journal-title":"Transpl Cell Ther"},{"issue":"3","key":"3938_CR20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","volume":"20","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Mu\u00f1oz A, Schneider MF, Mak RH, Kaskel F, Warady BA et al (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20(3):629\u2013637","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"3938_CR21","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/ndt\/gfg349","volume":"18","author":"FJ Hoek","year":"2003","unstructured":"Hoek FJ, Kemperman FA, Krediet RT (2003) A comparison between Cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 18(10):2024\u20132031","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"3938_CR22","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1097\/PCC.0000000000001228","volume":"18","author":"SN Avedissian","year":"2017","unstructured":"Avedissian SN, Bradley E, Zhang D, Bradley JS, Nazer LH, Tran TM et al (2017) Augmented renal clearance using population-based pharmacokinetic modeling in critically ill pediatric patients. Pediatr Crit Care Med 18(9):e388\u2013e94","journal-title":"Pediatr Crit Care Med"},{"key":"3938_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.723731","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, Wang Y, Ma Y, Wang P, Zhong J, Chu Y (2021) Augmented renal clearance: what have we known and what will we do? Front Pharmacol 12:723731","journal-title":"Front Pharmacol"},{"issue":"3","key":"3938_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/phar.70000","volume":"45","author":"VL Williams","year":"2025","unstructured":"Williams VL, Gerlach AT (2025) Establishing discordance rate of estimated glomerular filtration rate between serum creatinine-based calculations and cystatin-C-based calculations in critically ill patients. Pharmacotherapy 45(3):161\u2013168","journal-title":"Pharmacotherapy"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03938-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-025-03938-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03938-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:52:42Z","timestamp":1773309162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-025-03938-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3938"],"URL":"https:\/\/doi.org\/10.1007\/s00228-025-03938-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. Ethical approval was granted by the Institutional Review Board (IRB) of King Saud University under the title \u201cPharmacokinetics of vancomycin, meropenem, amikacin, and gentamicin in pediatric critically ill patients using novel renal biomarkers\u201d (Approval No. E-24-8697, dated May 16, 2024).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the parents or legal guardians of all participating children prior to their enrollment. To maintain confidentiality, all patient data were anonymized.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}